• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virus Genes . Surveillance reveals a prevalent pediatric A(H1N1)pdm09 virus with hemagglutinin substitutions S137P-R142K-V152I that diminish vaccin

tetano

Editor, Senior Moderator
Virus Genes


. 2026 Feb 4.
doi: 10.1007/s11262-026-02218-x. Online ahead of print.
Surveillance reveals a prevalent pediatric A(H1N1)pdm09 virus with hemagglutinin substitutions S137P-R142K-V152I that diminish vaccine efficacy

Lifeng Zhao[SUP] #[/SUP][SUP] 1 [/SUP], Jing Wang[SUP] #[/SUP][SUP] 2 [/SUP], Jihong Xu[SUP] 1 [/SUP], Jiane Guo[SUP] 1 [/SUP], Ping Zhang[SUP] 1 [/SUP], Xiaofang Guo[SUP] 1 [/SUP], Zhihong Zuo[SUP] 1 [/SUP], Ruihong Gao[SUP] 1 [/SUP], Li Gao[SUP] 1 [/SUP], Jitao Wang[SUP] 3 4 [/SUP]


Affiliations
Abstract

Influenza A(H1N1)pdm09 viruses pose a significant disease burden on children worldwide, with high rates of hospitalization and substantial morbidity and mortality. Outpatient < 18 years of age with upper respiratory infections (URIs) were enrolled through active surveillance at Shanxi Children's Hospital (SCH) between 7/1/2024 and 6/30/2025. Nasal swabs were collected for the detection of influenza virus and other respiratory pathogens by PCR-based methods. Influenza strains were obtained through in vitro culture, and their antigenic characterization were determined by hemagglutinin-inhibition (HI) assay. Genetic analyses were conducted using next-generation sequencing (NGS), while the fluorescence neuraminidase inhibition assay (FNIA) was employed to ascertain antiviral resistance. A total of 987 throat swab samples were collected. A(H1N1)pdm09 was the main pathogens causing URIs in children during the 2024-2025 influenza season and belongs to the 6B.1A.5a.2a evolutionary branch along with vaccine strains. Four novel HA and six NA non-synonymous substitutions were identified in pH1N1, which are related to antigenic drift and varying degrees of drug resistance, respectively. Three S137P-R142K-V152I-substituted strains were identified as low reactive strains, and strains with T188I, S247N, G249E, I264T, M314I, and K331R substitutions did not demonstrate a significant escalation in drug resistance. Despite the absence of drug-resistant A(H1N1)pdm09 strains in children, the emergence of low-response strains, attributable to mutations associated with antigen drift, necessitates continuous genomic monitoring to ensure preparedness for future seasonal influenza outbreaks.

Keywords: Influenza A(H1N1)pdm09 virus; Mutation; Next-generation sequencing; Upper respiratory infections.

 
Back
Top Bottom